<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000698424"><TermName>NG-nitro-L-arginine</TermName><TermPronunciation>(… NY-troh … AR-jih-neen)</TermPronunciation><TermDefinition><DefinitionText>A form of the amino acid arginine. An amino acid is a protein building block. NG-nitro-L-arginine is being studied in the treatment of cancer and other conditions. In cancer, it may stop the growth of tumor cells by blocking certain proteins needed for tumor cells to grow and by blocking blood flow to the tumor. It is a type of nitric oxide synthase inhibitor and an antiangiogenesis agent. Also called nitroarginine.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000733189" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;NG-nitro-L-arginine&quot;" language="en" id="_3"/><MediaLink ref="CDR0000733188" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;Ng-nitro-L-arginina&quot;" language="es" id="_4"/><SpanishTermName>Ng-nitro-L-arginina</SpanishTermName><SpanishTermDefinition><DefinitionText>Forma del aminoácido arginina. Un aminoácido es un elemento fundamental de las proteínas. La Ng-nitro-L-arginina está en estudio para el tratamiento de cáncer y otras afecciones. En el caso del cáncer, impide el crecimiento de las células tumorales al no dejar que  ciertas proteínas que un tumor necesita para crecer funcionen debidamente y no permitir que la sangre fluya hacia el tumor. Es un tipo de inhibidor de la sintasa del óxido nítrico y una sustancia antiangiogénica. También se llama nitroarginina.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2011-08-17</DateFirstPublished></GlossaryTerm>
